x
Ariana Pharma - Logo
[contact-form-7 404 "Not Found"]

  • Paris, FRANCE / Cambridge, MA, USA
  • 666-888-0000
  • info@arianapharma.com
Ariana Pharma - Logo
  • info@arianapharma.com
  • Paris, FRANCE / Cambridge, MA, USA
  • Contact Us
  • Home
  • Our Business
  • Our Technology
  • About Us
  • News
    • In The News
    • Publications
  • Real World Data
  • Careers
Logo

Contact Info

  • 58-60 Avenue de la Grande Armée, 75017, Paris, France
  • +33 1 44 37 17 00
  • info@arianapharma.com

47th Annual Meeting Of The EASL, April 2012, Barcelona , Spain

Asselah, T. et al. A four Gene molecular signature is better than IL28B polymorphism to predict treatment response to pegylated –interferon and ribavirin in chronic hepatitis C. in The European Association for the Study of the Liver (EASL) 47th Annual Meeting (2012).

Ariana Pharmaceuticals, The AI DRUG Development Company

  • Paris, FRANCE / Cambridge, MA, USA
  • Call Us: +33 144 37 17 00
  • info@arianapharma.com

Menu

  • About Us
  • Our business
  • Technology
  • In The News
  • Contact Us

Subscribe

Keep in touch and subscribe to our latest news

    Ariana Pharma © 2022 All Rights Reserved